CKD Diagnosis: eGFR Thresholds and Kidney Damage Criteria
CKD can be diagnosed with an eGFR of 60-89 mL/min/1.73 m² if there is evidence of kidney damage present for at least 3 months, but eGFR <60 mL/min/1.73 m² alone is sufficient to diagnose CKD regardless of whether kidney damage markers are present. 1
Understanding the Two-Part Definition
CKD requires either of the following criteria persisting for ≥3 months: 1, 2
- eGFR <60 mL/min/1.73 m² (with or without kidney damage markers)
- Evidence of kidney damage (with any eGFR level, including ≥60)
When eGFR is 60-89 mL/min/1.73 m² (Stage 2 CKD)
You must have documented kidney damage to diagnose CKD at this eGFR range. 1 Acceptable markers of kidney damage include: 1, 2
- Albuminuria: UACR ≥30 mg/g (most common marker)
- Pathological abnormalities on kidney biopsy
- Imaging abnormalities: structural changes, cysts, or other renal abnormalities on ultrasound/CT
- Urine abnormalities: persistent hematuria or other abnormal findings
- History of kidney transplantation
Without any of these damage markers, an eGFR of 60-89 mL/min/1.73 m² does not constitute CKD—it may represent normal kidney function, particularly in younger individuals. 1, 3
When eGFR is <60 mL/min/1.73 m² (Stage 3-5 CKD)
No additional markers are required. 1 An eGFR persistently <60 mL/min/1.73 m² for ≥3 months is diagnostic of CKD by itself, regardless of whether albuminuria or other damage markers are present. 2
Critical Confirmation Strategy for Borderline Cases
When creatinine-based eGFR is 45-59 mL/min/1.73 m² (Stage 3a) without other kidney damage markers, measure cystatin C to confirm true CKD. 4, 5 This is essential because:
- Approximately 23% of patients with creatinine-based eGFR 45-59 actually have normal kidney function when confirmed with cystatin C 4
- If cystatin C-based eGFR is ≥60 mL/min/1.73 m², CKD diagnosis is not confirmed 4
- If cystatin C-based eGFR is <60 mL/min/1.73 m², CKD diagnosis is confirmed 4
- The combined creatinine-cystatin C equation (eGFRcreat-cys) provides 94.9% accuracy and should guide clinical decisions 4, 5
Common Pitfall to Avoid
Do not diagnose CKD in patients with eGFR 60-89 mL/min/1.73 m² who lack evidence of kidney damage. 3 Misdiagnosing CKD has negative consequences including insurance implications, unnecessary patient anxiety, and inappropriate nephrology referrals. 3 Always verify that patients with Stage 1-2 CKD have documented albuminuria, structural abnormalities, or other damage markers before assigning the diagnosis. 1, 2
Staging Algorithm
Once CKD is confirmed, stage according to eGFR: 1
- Stage 1: eGFR ≥90 (requires kidney damage markers)
- Stage 2: eGFR 60-89 (requires kidney damage markers)
- Stage 3a: eGFR 45-59 (no damage markers required)
- Stage 3b: eGFR 30-44 (no damage markers required)
- Stage 4: eGFR 15-29 (no damage markers required)
- Stage 5: eGFR <15 or dialysis (no damage markers required)